ADH1C rs12292993: Alcohol Metabolism and Esophageal Cancer Risk
The rs12292993 variant is a single nucleotide polymorphism located within the ADH1C gene on chromosome 4. It encodes a subunit of alcohol dehydrogenase, an enzyme central to breaking down ethanol into acetaldehyde. Scientific research associates this variant with variations in alcohol oxidation speed and modulated risks of alcohol-associated esophageal cancer, particularly in specific ancestral cohorts.
What each genotype means
High enzyme activity
This genotype is often referred to in literature as ADH1C*1/*1. It is associated with a higher capacity to convert alcohol into acetaldehyde, which some research suggests may increase the risk of certain alcohol-related cancers in heavy drinkers. Please discuss any concerns regarding alcohol consumption or health risks with your clinician.
This genotype is common in many populations, though frequencies vary significantly by ancestry.
Intermediate enzyme activity
This genotype, often noted as ADH1C*1/*2, represents a combination of the two primary functional alleles. Research into how this specific combination influences alcohol metabolism rates and associated health risks remains mixed and context-dependent. Please discuss your health and lifestyle choices with a qualified healthcare provider.
This heterozygous genotype is found across diverse global populations at varying frequencies.
Lower enzyme activity
This genotype is often referred to in literature as ADH1C*2/*2. It is associated with a lower capacity to oxidize alcohol compared to the II genotype. While some studies investigate its role in alcohol-related health outcomes, the evidence is limited and results are often inconsistent across different ethnic groups. Please consult with your clinician regarding your health profile.
This genotype is relatively uncommon in many populations, including some Asian cohorts where the I allele is more prevalent.
Genetic Architecture and Location
The single nucleotide polymorphism rs12292993 is located within the alcohol dehydrogenase gene cluster situated on human chromosome 4 (4q23). Specifically, it maps to the ADH1C gene (alcohol dehydrogenase 1C, gamma polypeptide), which resides alongside related genes such as ADH1A and ADH1B as cataloged in [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/126). Variants in this genetic neighborhood are often inherited together in high linkage disequilibrium, forming regional haplotypes that collectively modulate alcohol degradation efficiency. Because alleles in this cluster are closely linked, distinguishing the precise standalone functional contribution of rs12292993 from neighboring variants like ADH1B polymorphisms remains an active area of genomic research.
Biological Role of ADH1C in Alcohol Metabolism
The primary role of the enzyme encoded by ADH1C is to catalyze the initial phase of alcohol metabolism in the liver and gastric mucosa. The enzyme oxidizes ethanol into acetaldehyde, a reactive and toxic intermediary, using nicotinamide adenine dinucleotide (NAD+) as an essential cofactor, as outlined by [OMIM Entry 103730](https://omim.org/entry/103730). Acetaldehyde is subsequently converted into non-toxic acetate by aldehyde dehydrogenase enzymes, primarily ALDH2. Polymorphisms within ADH1C can alter the catalytic properties and oxidation rates of the enzyme. Faster conversion rates cause a rapid temporary accumulation of acetaldehyde, whereas slower conversion extends systemic exposure to intact ethanol molecules.
Strength of Scientific Evidence and Health Associations
Evidence linking rs12292993 directly to health outcomes is currently classified as limited and varies across different ancestral backgrounds. While large-scale studies in the [GWAS Catalog](https://www.ebi.ac.uk/gwas/search?query=rs12292993) confirm that genetic variation across the ADH cluster strongly impacts alcohol use traits, aerodigestive tract cancers, and upper digestive health, associations specifically assigned to rs12292993 are heavily modulated by personal lifestyle habits. When paired with heavy alcohol intake, variations altering acetaldehyde generation correlate with altered rates of esophageal squamous cell carcinoma, as summarized in [PubMed Research on ADH Variants](https://pubmed.ncbi.nlm.nih.gov/?term=rs12292993). However, effect sizes are inconsistent across populations, largely because neighboring loci like ALDH2 (rs671) and ADH1B (rs1229984) exert stronger baseline effects.
Interpreting Results: What You Can and Cannot Do
Understanding an ADH1C rs12292993 genotype does not provide a definitive diagnosis of any medical condition, nor does it predict alcohol use disorders with certainty. Genetic susceptibility serves only as a biological framework that interacts directly with lifestyle choices, primarily personal alcohol consumption habits. Individuals who possess alleles linked to faster oxidation or higher acetaldehyde toxicity do not inherently develop disease unless exposed to significant amounts of alcohol over time. Furthermore, if you are undergoing pharmacogenetic screening for drug metabolism, always consult your physician or pharmacist regarding medication compatibility and dosage adjustments rather than making changes based on direct-to-consumer genetic panels.
How common is this variant?
The variant allele is frequent in East Asian populations, where it frequently co-occurs with other rapid-turnover ADH alleles, whereas it is observed at substantially lower frequencies in European-ancestry cohorts.
Frequently asked questions
Does carrying the rs12292993 variant mean I will get esophageal cancer?
No, carrying this variant does not mean you will develop cancer. The observed scientific association is contingent on significant alcohol consumption, as the variant merely influences how quickly ethanol converts to intermediate metabolites like acetaldehyde.
Can rs12292993 predict how severe my hangovers will be?
While ADH1C variants influence how rapidly ethanol is converted into acetaldehyde, hangovers are multifactorial. Downstream enzymes like ALDH2, overall hydration, sleep quality, and total alcohol consumed exert a much stronger influence on post-drinking symptoms.
Does this genetic variant change how I process medications?
Some medications share metabolic pathways with alcohol-metabolizing enzymes in the liver or stomach mucosa. If you are reviewing genetic data alongside your prescriptions, speak directly with your doctor or pharmacist before adjusting any therapeutic regimens.
Why is the evidence for rs12292993 considered limited?
Evidence is rated as limited because rs12292993 is closely linked to other influential variants across the chromosome 4 ADH cluster, making it challenging to separate its individual biological effects from neighboring genes like ADH1B.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12292993?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29